What does Takeda Pharmaceuticals Australia Pty Ltd do for the Australian Government?
Takeda Pharmaceuticals Australia Pty Ltd is an Australian Government contractor with 4 contracts worth $596.1M since 2020. Their largest government client is National Blood Authority, and their average contract value is $149.0M.
Key Metrics
How much does Takeda Pharmaceuticals Australia Pty Ltd win in government contracts each year?
View data table
| Year | Contracts | Value |
|---|---|---|
| 2020 | 1 | $109.5M |
| 2021 | 1 | $434.1M |
| 2022 | 1 | $30.2M |
| 2025 | 1 | $22.3M |
Who are Takeda Pharmaceuticals Australia Pty Ltd's biggest government clients?
| Agency | Contracts | Value | Share |
|---|---|---|---|
| National Blood Authority | 4 | $596.1M | 100.0% |
What categories does Takeda Pharmaceuticals Australia Pty Ltd supply to government?
| Category | Contracts | Value | Share |
|---|---|---|---|
| 5100-pharmaceuticals-code-5100 | 4 | $596.1M | 100.0% |
How does Takeda Pharmaceuticals Australia Pty Ltd win government contracts?
| Method | Contracts | Value | Share |
|---|---|---|---|
| limited | 3 | $573.8M | 75.0% |
| open | 1 | $22.3M | 25.0% |
What are Takeda Pharmaceuticals Australia Pty Ltd's largest government contracts?
| Contract | Agency | Value | Awarded |
|---|---|---|---|
| National Supply arrangement for imported immunoglobulin products | National Blood Authority | $434.1M | |
| Supply of Advate and Adynovate Imported Plasma and Recombinant Products | National Blood Authority | $109.5M | |
| Imported Plasma and Recombinant Products | National Blood Authority | $30.2M | |
| Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate | National Blood Authority | $22.3M |
What are Takeda Pharmaceuticals Australia Pty Ltd's most recent government contracts?
| Contract | Agency | Value | Date |
|---|---|---|---|
| Procurement of Imported Plasma and Recombinant Products (IPRP) – Adynovate | National Blood Authority | $22.3M | |
| Imported Plasma and Recombinant Products | National Blood Authority | $30.2M | |
| National Supply arrangement for imported immunoglobulin products | National Blood Authority | $434.1M | |
| Supply of Advate and Adynovate Imported Plasma and Recombinant Products | National Blood Authority | $109.5M |
Who competes with Takeda Pharmaceuticals Australia Pty Ltd for government contracts?
Other suppliers winning contracts from the same agencies in similar categories.
| Supplier | Contracts | Value |
|---|---|---|
| CSL Behring (Australia) Pty Ltd | 3 | $2.19B |
| Grifols Australia Pty Ltd | 1 | $891.9M |
| Roche Products Pty Ltd | 2 | $670.9M |
| Octapharma Australia Pty Ltd | 1 | $329.7M |
| Sanofi-Aventis Australia Pty Ltd | 2 | $243.4M |
| Pfizer Australia Pty Ltd | 2 | $91.2M |
What is Takeda Pharmaceuticals Australia Pty Ltd's registered business information?
- Australian Business Number (ABN)
- 71095610870
- Registered Name
- Takeda Pharmaceuticals Australia Pty Ltd
- Government Contracting Period
- 2020 – 2025
Verify entity details on the Australian Business Register.
Registered Business Details
- Entity Type
- Australian Private Company
- ASIC Company Type
- Proprietary Limited
- ABN Status
- Active
- GST
- Registered
- ACN
- 095610870
- ABN
- 71095610870 verify ↗
- State
- NSW
- Postcode
- 2000
- Incorporated
- 16 January 2001 (25 years ago)
Source: Australian Business Register (ABR) + ASIC Companies Register. View on ABN Lookup ↗
Procurement Categories
UNSPSC categories where Takeda Pharmaceuticals Australia Pty Ltd is active.
Track Takeda Pharmaceuticals Australia Pty Ltd's government contracts
Get alerts when new contracts are awarded, expiring contracts come up for recompete, and competitors win in your categories.
No credit card required. Scout plans from US$49/mo.
Explore more
View procurement map · Browse all suppliers · Search contracts · National Blood Authority profile